Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma is a research paper published in Journal for ImmunoTherapy of Cancer (2020). On theSindex it has a DataRank of 0.754. It has been cited 151 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.754
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Astellas Foundation for Research on Metabolic Disorders
Grant: Postdoctoral Fellowship
National Foundation for Cancer Research
Grant: Fellow
Harvard Ludwig Cancer Center
Grant: Research Grant
Norway-Romania joint project
Grant: 4SEE P4/30.06.2014
National Cancer Institute
Grant: P01-CA080124
National Cancer Institute
Grant: Proton Beam/Federal Share Program
National Cancer Institute
Grant: R01-CA208205
National Cancer Institute
Grant: R35-CA197743
National Cancer Institute
Grant: R41-CA213678
National Cancer Institute
Grant: U01-CA224173
Bayer
Grant: Research Agreement
NCI NIH HHS
Grant: R41 CA213678
NCI NIH HHS
Grant: R35 CA197743
NCI NIH HHS
Grant: P01 CA080124
NCI NIH HHS
Grant: R01 CA208205
National Institutes of Health
Grant: 1R41CA213678-01A1
Development, Characterization & Commercialization of a Viably Frozen, Patient-Inclusive Hepatocellular Carcinoma Tumor Bank
National Institutes of Health
Grant: 5R01CA208205-03
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
National Institutes of Health
Grant: 1P01CA080124-01A1
Core--Bioengineering
National Institutes of Health
Grant: 5R35CA197743-05
Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment
FWCI
7.23
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of DFNA5 regulates immune cells infiltration and exhaustion
Additional file 1 of DFNA5 regulates immune cells infiltration and exhaustion
Additional file 1 of Effects of regorafenib on the mononuclear/phagocyte system and how these contribute to the inhibition of colorectal tumors in mice
Additional file 1 of Effects of regorafenib on the mononuclear/phagocyte system and how these contribute to the inhibition of colorectal tumors in mice
Additional file 2 of Effects of regorafenib on the mononuclear/phagocyte system and how these contribute to the inhibition of colorectal tumors in mice
Additional file 2 of Effects of regorafenib on the mononuclear/phagocyte system and how these contribute to the inhibition of colorectal tumors in mice
Additional file 1 of Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment
Additional file 1 of Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment